Ring-Finger Protein 126 (RNF126) Promotes Anoikis Resistance and Peritoneal Colonization in Ovarian Cancer

Area of Science:

• Oncology
• Molecular Biology
• Gynecologic Oncology

Background:

• Ovarian cancer (OC) is a lethal gynecologic malignancy, often diagnosed at advanced stages with peritoneal metastasis.
• Current therapeutic strategies for advanced OC require novel approaches targeting peritoneal colonization.

Purpose of the Study:

• To investigate the role of Ring-finger protein 126 (RNF126), an E3 ubiquitin ligase upregulated in OC, in peritoneal colonization.
• To determine the molecular mechanisms by which RNF126 influences OC cell behavior and metastasis.

Main Methods:

• RNF126 depletion in OC cells to assess proliferation under normal and anchorage-independent conditions.
• In vitro anoikis resistance assays.
• In vivo peritoneal colonization studies in immunodeficient mice.
• Analysis of NF-κB activation in OC cells under floating conditions.

Main Results:

• RNF126 depletion reduced OC cell growth under anchorage-independent conditions, indicating impaired anoikis resistance.
• RNF126 promoted anoikis resistance in vitro and enhanced peritoneal colonization in vivo in a RING domain-dependent manner.
• RNF126 activated the transcription factor NF-κB in floating OC cells, which was crucial for anchorage-independent growth and peritoneal colonization.

Conclusions:

• RNF126 plays a significant role in promoting ovarian cancer peritoneal colonization by conferring anoikis resistance via NF-κB activation.
• RNF126 represents a potential therapeutic target for preventing or treating peritoneally colonized ovarian cancer.